Training activity information
Details
Review viral screening results prior to storage to ensure compliance with HFEA regulations and make the appropriate storage decision
Type
Entrustable training activity (ETA)
Evidence requirements
Evidence the activity has been undertaken by the trainee repeatedly, consistently, and effectively over time, in a range of situations. This may include occasions where the trainee has not successfully achieved the outcome of the activity themselves. For example, because it was not appropriate to undertake the task in the circumstances or the trainees recognised their own limitations and sought help or advice to ensure the activity reached an appropriate conclusion.
Reflection at multiple timepoints on the trainee learning journey for this activity.
Considerations
- Implication of cross contamination
- Viral testing methods and laboratory accreditation for tests
- Local guidance for storage/treatment
- HFEA regulations and Code of Practice
- Professional body guidance
- National and international regulation
- Patient pathway for positive results
Reflective practice guidance
The guidance below is provided to support reflection at different time points, providing you with questions to aid you to reflect for this training activity. They are provided for guidance and should not be considered as a mandatory checklist. Trainees should not be expected to provide answers to each of the guidance questions listed.
Before action
- What are the specific HFEA regulations for viral screening that must be adhered to before sample storage, and how will you ensure your review and storage decision fully comply with these regulatory standards?
- How will you ensure that your decision-making process demonstrates safe and effective practice, minimising risk of cross-contamination or non-compliance?
- What do you already know about HFEA regulatory issues with regard to cryostorage and the interpretation of viral screening results?
- What possible challenges might you face in interpreting borderline results, identifying discrepancies in documentation, or applying complex regulatory clauses, and how might you handle them?
- When would it be beyond your scope of practice, requiring you to seek advice or help from a senior scientist or regulatory lead, for example, if a viral screening result is ambiguous or an exception is requested?
- How do you feel about embarking on this training activity, given the critical importance of regulatory compliance and patient safety?
- What specific knowledge about HFEA regulations pertaining to viral screening and storage decisions do you aim to deepen?
- What specific insights do you hope to gain regarding the practical application of regulatory requirements to ensure data integrity and make appropriate storage decisions?
- Consult actions identified following previous experiences with regulatory reviews, audits, or quality control processes.
- Identify important information you need to consider before embarking, such as the latest HFEA guidelines on viral screening, local laboratory policies for result interpretation, or any previous audit findings related to sample storage.
In action
- During the activity, is anything unexpected occurring? For instance, do you find conflicting information, unclear results, or a regulatory nuance that is not immediately apparent when reviewing the viral screening results?
- How do you react to the unexpected development? Do you adjust your review process or seek immediate consultation to ensure compliance? How does it affect your ability to make the appropriate storage decision independently?
- What is the immediate conclusion or outcome? What do you learn in that moment about navigating HFEA regulations or making critical storage decisions with unexpected information?
On action
- Summarise the key points of your review process for viral screening results, including the specific HFEA regulations you considered and the decision you made.
- Describe any specific events, actions, or interactions that felt important, such as encountering ambiguous results or conflicting information, and your own feelings during the review.
- Include any ‘reflect-in-action’ moments where you had to adapt your review process or seek immediate consultation to ensure compliance with HFEA regulations.
- Identify what learning you can take from this experience regarding navigating HFEA regulations and making critical storage decisions based on viral screening results.
- What strengths did you demonstrate in applying regulatory standards and ensuring compliance?
- Were there any skill or knowledge gaps evident, particularly in interpreting complex results or understanding specific regulatory nuances?
- Compare this experience against previous regulatory reviews; has your practice in ensuring compliance and making appropriate decisions improved?
- Identify any challenges you experienced (e.g., unclear results, regulatory ambiguity) and how you reacted to them.
- Did you need to seek advice or clarification from a senior colleague or regulatory guidance?
- What will you do differently next time you review viral screening results for storage?
- Has anything changed in terms of how you would approach complex or ambiguous results?
- Do you need to practise any aspect of this activity further, such as staying updated on HFEA regulations or interpreting specific viral screening reports?
Beyond action
- How has your understanding of HFEA regulations regarding viral screening and storage decisions deepened through your various experiences in reviewing results and making storage determinations?
- What challenges have you consistently observed in ensuring compliance with regulatory requirements, and how has your approach to managing these challenges evolved, considering past learning and actions?
- How do you apply your accumulated knowledge and critical appraisal skills to ensure ethical and compliant storage decisions, contributing to the safety and integrity of the cryobank, and how does this evolve with new information or regulations?
Relevant learning outcomes
| # | Outcome |
|---|---|
| # 4 |
Outcome
Perform cryopreservation, thawing and warming of gametes within the regulatory HFEA framework. |
| # 7 |
Outcome
Practice in accordance with quality management and regulatory standards. |
| # 8 |
Outcome
Demonstrate safe and effective practice, minimising risk to all staff and patients. |